IDO and TGF-β Inhibitors for the Treatment of Lung Cancer
Author:
Publisher
Springer Nature Singapore
Link
https://link.springer.com/content/pdf/10.1007/978-981-99-7141-1_9
Reference92 articles.
1. Adedokun KA, Imodoye SO, Bello IO, Lanihun A-A, Bello IO (2023) Therapeutic potentials of medicinal plants and significance of computational tools in anti-cancer drug discovery. In: Egbuna C, Rudrapal M, Tijjani H (eds) Drug discovery update, phytochemistry, computational tools and databases in drug discovery. Elsevier, Amsterdam, pp 393–455., ISBN 9780323905930. https://doi.org/10.1016/B978-0-323-90593-0.00017-4
2. Arteaga CL, Hurd SD, Winnier AR, Johnson MD, Fendly BM, Forbes JT (1993) Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression. J Clin Invest 92(6):2569–2576. https://doi.org/10.1172/JCI116871
3. Avila-Carrasco L, Majano P, Sánchez-Toméro JA, Selgas R, López-Cabrera M, Aguilera A, González Mateo G (2019) Natural plants compounds as modulators of epithelial-to-mesenchymal transition. Front Pharmacol 10:715. https://doi.org/10.3389/fphar.2019.00715
4. Bagchi M, Patel S, Zafra-Stone S, Bagchi D (2011) Selected herbal supplements and nutraceuticals. In: Gupta RC (ed) Reproductive and developmental toxicology. Academic, Cambridge, MA, pp 385–393. https://doi.org/10.1016/B978-0-12-382032-7.10030-X. ISBN 9780123820327
5. Beatty GL, O'Dwyer PJ, Clark J, Shi JG, Bowman KJ, Scherle PA, Newton RC, Schaub R, Maleski J, Leopold L, Gajewski TF (2017) First-in-human phase I study of the Oral inhibitor of Indoleamine 2,3-Dioxygenase-1 Epacadostat (INCB024360) in patients with advanced solid malignancies. Clin Cancer Res 23(13):3269–3276. https://doi.org/10.1158/1078-0432.CCR-16-2272
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3